PMC5846227_01
The patient developed an intensely pruritic, maculopapular rash during the second day of the first desensitization protocol
13223_2018_233_Fig1_HTML.jpg
PMC5846227_01_13223_2018_233_Fig1_HTML.jpg
Fig1
The following day, she developed a diffuse, pruritic, maculopapular rash (Fig. 1).